HealthQuill AbbVie
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs Pharma

AbbVie’s drug-resistant abdominal infection medicine gets US nod

HQ Team February 10, 2025: The U.S. Food and Drug Administration (FDA) has approved Emblaveo, a new antibiotic combination of aztreonam and avibactam,.

Read More
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
Drugs Health Medical

Supernus’ injection to treat advanced Parkinson’s gets US regulator’s nod

Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.

Read More
The European Commission has granted Pfizer Inc., marketing authorisation for a drug to treat adult patients with intra-abdominal infections, hospital-acquired pneumonia and complex urinary tract infections.
Drugs Health Pharma

EC marketing nod for Pfizer drug to fight antimicrobial resistance

HQ Team April 22, 2024: The European Commission has granted Pfizer Inc., marketing authorisation for a drug to treat adult patients with intra-abdominal.

Read More